1 / 12

Morbidity and Mortality Rounds

Morbidity and Mortality Rounds. Dr. Shounak Das July 27, 2007. History. HPI : 53 y.o. Hispanic female admitted through the ER with fever + hypotension h/o diabetes, morbid obesity, CAD 8 years s/p CABG complicated by CVA with residual hemiplegia 1 month PTA admitted with PE

vincent-moody
Télécharger la présentation

Morbidity and Mortality Rounds

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Morbidity and Mortality Rounds Dr. Shounak Das July 27, 2007

  2. History HPI: • 53 y.o. Hispanic female admitted through the ER with fever + hypotension • h/o diabetes, morbid obesity, CAD 8 years s/p CABG complicated by CVA with residual hemiplegia • 1 month PTA admitted with PE • PPM placed 3 weeks PTA • 1 day PTA developed chills, nausea, vomiting

  3. History PMH: • diabetes • CAD • CVA • dyslipidemia PSH: • CABG • R knee surgery • lap choly • hypertension • morbid obesity • pulmonary embolus • PPM placement • IVC filter

  4. meds (home): aspirin 81 mg daily lisinopril 10 mg daily actos 45 mg daily 70/30 insulin 20 units bid toprol XL 50 mg daily allergies: NKDA History

  5. History FH: • +ve for diabetes + hypertension SH: • married • non-smoker; no EtOH

  6. History ROS: • denies chest pain or palpitations • no cough • denies abdominal pain or recent change in bowel habits • denies dysuria • weight gain is noted • she complains of slight headache

  7. Vital signs: HR: 88 (reg) RR: 24 BP: 80/51 T°: 103.4 HEENT: PERRLA/EOMI/anicteric/oropharynx normal/no lymphadenopathy Chest: clear to auscultation bilaterally/mild inflammation around pacemaker pocket; no fluctuance/drainage Physical Exam • General: • ill-looking obese patient

  8. CVS: RRR/NL S1 + S2/no extra sounds, rubs, or murmurs Abdo: Nl bowel sounds/ soft, non-tender/no hepatosplenomegaly Neuro: CN II-XII intact/R-sided weakness (U>L) Extremities: +1 bilateral ankle edema Skin: no rashes Physical Exam

  9. Labs 60%N 16%L 12%M 11%B 10.9 132 107 37 194 14.1 106 3.0 16 1.6 32.4 AG = 9 Ca2+: 6.3 7.6corr Mg2+: 0.8 TP: 5.3 Alb: 2.4 INR: 1.3 fibrinogen: 309 CRP: 11 AST: 27 ALT: 13 Alk Phos: 85 T bili: 0.9

  10. Labs • CXR: low volumes; no infiltrate • u/a: 25 WBC/hpf • blood cultures: 2/2 +ve for MSSA • TEE: RA lead – 2-3 mm mobile vegetation/thrombus

  11. Course in Hospital • started on IV vancomycin initially, then switched to nafcillin once sensitivities confirmed • started on pressors • intubated hospital day #2 • started on CVVHD hospital day #8 for ARF • pacemaker removed hospital day #11 • MOF; persistent hypotension despite maximal pressors • withdrawal of care hospital day # 15

  12. Pacemaker Infections • incidence roughly 5% • 90% of these are “pocket infections” • remaining are “deeper infections” i.e. “device –related endocarditis” • risk factors: diabetes, recent manipulation of device, temporary pacers • 90% caused by s. epidermis or s. aureus • 1/3rd “early” (3-6 mos.); 2/3rds “late” (after 3-6 mos.) • lead removal recommended for device-related endocarditis

More Related